AGM
ABEO icon

Alpine Global Management’s Abeona Therapeutics ABEO Stock Holding History

Alpine Global Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-436
Closed -$17K – 301
2021
Q2 		$17K Buy
+436
New +$17.8K ﹤0.01% 302
2020
Q3 		– Sell
-1,000
Closed -$73K – 228
2020
Q2 		$73K Sell
1,000
-2,044
-67% -$141K 0.01% 303
2020
Q1 		$160K Sell
3,044
-16,956
-85% -$1.13M 0.03% 161
2019
Q4 		$1.64M Buy
+20,000
New +$1.41M 0.35% 70

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Alpine Global Management's ABEO Position: Q3 2021 in Review

Alpine Global Management sold out of Abeona Therapeutics (ABEO) in Q3 2021, closing a stake of 436 shares — an estimated $17K sold.

Alpine Global Management first reported a position in ABEO in Q4 2019 and held it in 4 quarters. The position peaked at $1.64M in Q4 2019. 58 funds tracked by Wall St. Rank hold ABEO as of Q3 2021.

  • Alpine Global Management reported no remaining Abeona Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Alpine Global Management sold 436 Abeona Therapeutics shares in Q3 2021, an estimated $17K.
  • Alpine Global Management first reported a position in Abeona Therapeutics in Q4 2019 and held it in 4 quarters.
  • Alpine Global Management's Abeona Therapeutics position peaked at $1.64M in Q4 2019.
  • 58 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2021.

Based on Alpine Global Management's 13F filing for Q3 2021, filed 12 Nov 2021.